XML 99 R87.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity - Summary of Awards Granted to Non-employee Directors (Details) - Non-employee Directors - $ / shares
12 Months Ended
Apr. 29, 2023
Apr. 30, 2022
May 01, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested Outstanding beginning balance (in shares) 17,956    
Awarded (in shares) 43,334 32,731 33,000
Issued (in shares) (15,540) (14,775) (33,000)
Non-vested Outstanding ending balance (in shares) 45,750 17,956  
Weighted average grant date fair value      
Weighted average grant date fair value - beginning balance (in dollars per share) $ 47.35    
Weighted average grant date fair value, awarded (in dollars per share) 36.13 $ 47.37 $ 28.76
Weighted average grant date fair value, issued (in dollars per share) 36.04 47.39 $ 28.76
Weighted average grant date fair value - ending balance (in dollars per share) $ 40.56 $ 47.35  
Non-Employee Director Awards      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Awarded (in shares) 15,540 14,775 33,000
Issued (in shares) (15,540) (14,775) (33,000)
Deferred Non-Employee Director Awards      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested Outstanding beginning balance (in shares) 17,956    
Awarded (in shares) 27,794 17,956  
Non-vested Outstanding ending balance (in shares) 45,750 17,956